These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24350100)

  • 1. Overactive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introduction.
    Rahnama'i MS; Van Koeveringe GA; Van Kerrebroeck PE
    Nephrourol Mon; 2013 Sep; 5(4):934-45. PubMed ID: 24350100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of prostanoids in urinary bladder physiology.
    Rahnama'i MS; van Kerrebroeck PE; de Wachter SG; van Koeveringe GA
    Nat Rev Urol; 2012 Mar; 9(5):283-90. PubMed ID: 22410675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.
    Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK
    Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of prostanoids in the urinary bladder function and a potential use of prostanoid-targeting pharmacological agents in bladder overactivity treatment.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2015; 72(1):13-9. PubMed ID: 25850196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is coexistent overactive-underactive bladder (with or without detrusor overactivity and underactivity) a real clinical syndrome? ICI-RS 2019.
    Mancini V; Tarcan T; Serati M; Wyndaele M; Carrieri G; Abrams P
    Neurourol Urodyn; 2020 Jul; 39 Suppl 3():S50-S59. PubMed ID: 32032454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of phosphodiesterases in bladder pathophysiology.
    Rahnama'i MS; Ückert S; Hohnen R; van Koeveringe GA
    Nat Rev Urol; 2013 Jul; 10(7):414-24. PubMed ID: 23670184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprostanes evoke contraction of the murine and human detrusor muscle via activation of the thromboxane prostanoid TP receptor and Rho kinase.
    Molnár PJ; Dér B; Borsodi K; Balla H; Borbás Z; Molnár K; Ruisanchez É; Kenessey I; Horváth A; Keszthelyi A; Majoros A; Nyirády P; Offermanns S; Benyó Z
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F537-F547. PubMed ID: 33491563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
    Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The five primary prostaglandins stimulate contractions and phasic activity of the urinary bladder urothelium, lamina propria and detrusor.
    Stromberga Z; Chess-Williams R; Moro C
    BMC Urol; 2020 Apr; 20(1):48. PubMed ID: 32349725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivity.
    Drake MJ; Kanai A; Bijos DA; Ikeda Y; Zabbarova I; Vahabi B; Fry CH
    BJU Int; 2017 Jan; 119(1):22-29. PubMed ID: 27444952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity.
    Füllhase C; Hennenberg M; Giese A; Schmidt M; Strittmatter F; Soler R; Gratzke C; Andersson KE; Stief C
    J Urol; 2013 Oct; 190(4):1430-5. PubMed ID: 23545097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011.
    Kanai A; Zabbarova I; Oefelein M; Radziszewski P; Ikeda Y; Andersson KE
    Neurourol Urodyn; 2012 Mar; 31(3):300-8. PubMed ID: 22275187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Biomarkers Utilized to Define and Manage Overactive Bladder Syndrome.
    Kuo HC
    Low Urin Tract Symptoms; 2012 Mar; 4 Suppl 1():32-41. PubMed ID: 26676698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overactive bladder: urodynamic characteristics of detrusor overactivity due to the etiology of low urinary tract dysfun- ction].
    Philippova ES; Bazhenov IV; Ziryanov AV; Zhuravlev VN
    Urologiia; 2021 Jun; (3):39-44. PubMed ID: 34251099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the pelvic nerve increases bladder capacity in the prostaglandin E
    Langdale CL; Hokanson JA; Sridhar A; Grill WM
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F657-F665. PubMed ID: 28615244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.
    Peyronnet B; Mironska E; Chapple C; Cardozo L; Oelke M; Dmochowski R; Amarenco G; Gamé X; Kirby R; Van Der Aa F; Cornu JN
    Eur Urol; 2019 Jun; 75(6):988-1000. PubMed ID: 30922690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Urinary Tract Symptoms: What's New in Medical Treatment?
    Peyronnet B; Brucker BM; Michel MC
    Eur Urol Focus; 2018 Jan; 4(1):17-24. PubMed ID: 29665997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
    Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.
    Yamaguchi O
    Int J Urol; 2013 Jan; 20(1):28-39. PubMed ID: 23190275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder.
    Jiménez-Cidre MA; López-Fando L; Mora AM;
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):221-227. PubMed ID: 30862379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.